Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Previously unconnected molecular networks conspire to promote cancer

23.12.2011
Inflammatory signaling blocks NUMB’s ability to deaden NOTCH1-driven tumor development

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

Working in liver cancer cell lines, the team discovered a mechanism by which tumor necrosis factor alpha (TNFá) stimulates tumor formation, said senior author Mien-Chie Hung, Ph.D., professor and chair of MD Anderson's Department of Molecular and Cellular Oncology. Hung also is MD Anderson's vice president for basic research.

"We've discovered cross-talk between the TNFá inflammation and NOTCH signaling pathways, which had been known to separately promote cancer development and growth," Hung said. Liver cancer is one of several cancers, including pancreatic and breast, associated with inflammation.

Their findings have potential implications for a new class of anti-cancer drugs currently in clinical trials. "Pharmaceutical companies are developing NOTCH inhibitors," Hung said. "TNFá now presents a potential resistance mechanism that activates NOTCH signaling in a non-traditional way."

Pathways also unite in colon, lung, prostate cancers

"In addition, co-activation of these two pathways was also observed in colon, lung and prostate cancers, suggesting that the cross-talk between these two pathways may be more generally relevant," Hung said.

However, TNFá also presents an opportunity to personalize therapy, Hung said. The presence of TNFá or a separate protein that it activates called IKK alpha may serve as useful biomarkers to guide treatment.

"If a patient has only NOTCH activated, then the NOTCH inhibitor alone might work. But if TNFá or IKKá are also activated, then the NOTCH inhibitor alone might not work very well and combination therapy would be warranted," Hung said.

"We'll try this in an animal model and then go to clinical trial if it holds up," Hung said.

A path from inflammation to liver cancer

In a series of experiments, Hung and colleagues connected the following molecular cascade:

TNFá, a proinflammatory cytokine, signals through a cell's membrane, activating IKKá, a protein kinase that regulates other proteins by attaching phosphate groups (one phosphate atom, four oxygen atoms) to them.

IKKá moves into the cell nucleus, where it phosphorylatesFOXA2, a transcription factor that normally fires up the tumor suppressor NUMB.

NUMB usually blocks a protein called NICD, the activated portion of NOTCH1 that slips into the cell nucleus to activate genes that convert the normal cell to a malignant one.

But when FOXA2 is phosphorylated, it does not activate NUMB. With NUMB disabled, NOTCH1 is activated. New understanding, new targets for cancer therapy

In liver cancer (hepatocellular carcinoma) tumors, IKKá, the phosphorylated version of FOXA2 and NOTCH1 are expressed more heavily than in normal liver tissue. Expression of all three is correlated in liver cancer tumors, the team found.

The authors conclude that identifying the link between TNFá and NOTCH1 pathways provides a new starting point for understanding the molecular basis for TNFá-related tumor growth and for identifying new targets for cancer therapy.

Finding ways to inhibit FOXA2 phosphorylation or to activate NUMB would provide new options for treating and perhaps preventing cancer, Hung said.

Co-authors with Hung are first author Mo Liu, Dung-Fang Lee, Chun-Te Chen, Hong-Jen Lee, Chun-Ju Chang, Jung-Mao Hsu, Hsu-Ping Kuo, Weiya Xia, Yongkun Wei, Chao-Kai Chou, and Yi Du, all of MD Anderson's Department of Molecular and Cellular Oncology; Liu also is a graduate student in The University of Texas Graduate School of Biomedical Sciences at Houston, a joint program of MD Anderson and The University of Texas Health Science Center at Houston; Chia-Jui Yen, National Cheng Kung University College of Medicine, Tainan, Taiwan; Long-Yuan Li, Wei-Chao Chang and Pei-Chun Chiu of the Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan; Debanjan Dhar and Michael Karin, Laboratory of Gene Regulation and Signal Transduction, University of California, San Diego; and Chung-Hsuan Chen, The Genomics Research Center, Academica Sinica, Taipei, Taiwan. Wei-Chao Chang also is associated with Academic Sinica.

Funding for this research was provided by the National Cancer Institute, including MD Anderson's Cancer Center Support Grant from the NCI, National Science Council of Taiwan, Taiwan Department of Health; The MD Anderson-China Medical University and Hospital Sister Institution Fund, the Kadoorie Charitable Foundation and a research assistant scholarship to Mo Liu by the University of Texas Graduate School of Biomedical Sciences at Houston.

Scott Merville | EurekAlert!
Further information:
http://www.mdanderson.org

More articles from Life Sciences:

nachricht Enzyme with surprising dual function
24.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Flexibility and arrangement - the interaction of ribonucleic acid and water
24.01.2018 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Optical Nanoscope Allows Imaging of Quantum Dots

Physicists have developed a technique based on optical microscopy that can be used to create images of atoms on the nanoscale. In particular, the new method allows the imaging of quantum dots in a semiconductor chip. Together with colleagues from the University of Bochum, scientists from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute reported the findings in the journal Nature Photonics.

Microscopes allow us to see structures that are otherwise invisible to the human eye. However, conventional optical microscopes cannot be used to image...

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Physicists have learned to change the wavelength of Tamm plasmons

24.01.2018 | Physics and Astronomy

When the eyes move, the eardrums move, too

24.01.2018 | Health and Medicine

Deaf children learn words faster than hearing children

24.01.2018 | Health and Medicine

VideoLinks Science & Research
Overview of more VideoLinks >>>